FDA Funding Advocates Urge Congress, OMB To Heed Science Board Proposals

The Alliance for a Stronger FDA on Monday (Sept. 28) urged Congress, the White House Office of Management and Budget, and HHS to pay close attention to a recent FDA Science Board report that warns new agency hiring authority and funding is needed to spur medical product innovation. Acting FDA-Commissioner Stephen Ostroff likewise recently said he hopes the board's recommendations will influence lawmakers to adequately fund the agency as they move forward on the House 21st Century Cures bill and...